Torthaí cuardaigh - Haeri Seol
- 1 - 4 toradh as 4 á dtaispeáint
-
1
Clinical utility of serum biomarkers in Duchenne muscular dystrophy de réir Yetrib Hathout, Haeri Seol, M H Han, Aiping Zhang, Kristy J. Brown, Eric P. Hoffman
Foilsithe / Cruthaithe 2016Revisão -
2
Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients de réir Yetrib Hathout, Ramya Marathi, Sree Rayavarapu, Aiping Zhang, Kristy J. Brown, Haeri Seol, Heather Gordish‐Dressman, Sebahattin Çirak, Luca Bello, Kanneboyina Nagaraju, Terry Partridge, Eric P. Hoffman, Shin’ichi Takeda, Jean K. Mah, Erik Henricson, Craig M. McDonald
Foilsithe / Cruthaithe 2014Artigo -
3
Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study de réir Simina M. Boca, Maki Nishida, Michael A. Harris, Shruti Rao, Amrita K. Cheema, Kirandeep Gill, Haeri Seol, Lauren P. Morgenroth, Erik Henricson, Craig M. McDonald, Jean K. Mah, Paula R. Clemens, Eric P. Hoffman, Yetrib Hathout, Subha Madhavan
Foilsithe / Cruthaithe 2016Artigo -
4
Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children de réir Yetrib Hathout, Laurie S. Conklin, Haeri Seol, Heather Gordish‐Dressman, Kristy J. Brown, Lauren P. Morgenroth, Kanneboyina Nagaraju, Christopher R. Heier, Jesse M. Damsker, John N. van den Anker, Erik Henricson, Paula R. Clemens, Jean K. Mah, Craig M. McDonald, Eric P. Hoffman
Foilsithe / Cruthaithe 2016Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Internal medicine
Medicine
Bioinformatics
Duchenne muscular dystrophy
Endocrinology
Muscular dystrophy
Disease
Biochemistry
Biomarker discovery
Clinical trial
Corticosteroid
Creatine
Creatinine
Drug
Dystrophin
Gene
Genetics
Hormone
Intensive care medicine
Metabolite
Metabolomics
Pathology
Pharmacodynamics
Pharmacokinetics
Pharmacology
Physical therapy
Physiology
Prednisolone
Proteomics